Web Exclusive: Vitamin B 3 (Niacin) Can Help Control Cholesterol
Cholesterol drugs account for some of the greatest profit sources ever developed by the pharmacological industry.
Actavis buying Warner Chilcott in $8.5B deal
Actavis is buying Warner Chilcott in an all-stock deal valued at about $8.5 billion that would create the third-biggest specialty pharmaceutical company in the U.S. market.
Thu May 16, 2013
Esperion Therapeutics seeking $70 million in IPO filing
In documents filed Tuesday with the U.S. Securities and Exchange Commission , the company declared that it is setting a $70 million goal for the initial public offering and will be traded on the Nasdaq Stock Market under the symbol ESPR .
Pfizer Puts Lipitor Site Up For Sale as Patent Expiration Causes Over-Capacity
The plant that manufactures the API for Lipitor is the third Irish facility to be sold by Pfizer as patent expiration and lower sales have caused a redundancy in operations.
Wed May 15, 2013
Ranbaxy generic drug investigation settled, includes $500M criminal civil costs
Ranbaxy USA, Inc. has agreed to plead guilty to criminal information charging violations of the Food and Drug and Cosmetic Act and other criminal statutes involving the manufacturing and distribution of Atorvastatin, the generic form of Lipitor.
Tue May 14, 2013
Ranbaxy Pays $500 Million Fine for Selling Bad Batches of Generic Medicines
Ranbaxy, a subsidiary of Japanese pharmaceutical company Daiichi Sankyo, has paid a $500 million fine and pled guilty to selling adulterated drugs manufactured in India .
KSAT-TV San Antonio
Rx price check: Blockbuster generics vary widely
A price check of five blockbuster drugs that now have generics on the market, including Lipitor for cholesterol and the blood-thinner Plavix, shows significant price differences depending on which pharmacy you shop.
Grapefruit and prescription meds, when are they safe to mix?
Doctors advise patients who take statin drugs and some other medication to refrain from drinking grapefruit juice or eating the fruit.
Mon May 13, 2013
Maker of generic Lipitor pleads guilty to selling "adulterated drugs"
Indian generic drug-maker Ranbaxy Laboratories pleaded guilty today to seven federal criminal counts of selling adulterated drugs with intent to defraud, failing to report that its drugs didn't meet specifications, and making intentionally false statements to the government.
Teva: An Ideal Long-Term Pharma Stock
A study released by the IMS Institute for Health Informatics finds that per capita spending on medicines declined by $33 in 2012.
Are You Taking This Dangerous Drug?
On May 3, 2013, the FDA approved a Big Pharma Cartel founding member Merck drug Liptruzet.
Fri May 10, 2013
Actavis, Warner Chilcott discussing combination
Drugmakers Actavis Inc. and Warner Chilcott PLC said Friday that they in early talks about a possible combination of the two companies.
Thu May 09, 2013
Report: US medicine spending shows rare dip in 2012
Spending on prescription medicines in the U.S. fell for the first time in more than five decades last year.
The Indian Express
Ranbaxy Jan-Mar net profit plunges by 90%
Ranbaxy Laboratories missed analysts' estimates for its January-March quarter, reporting a 90 per cent decline in net profit at Rs 126 crore.
Professor explores generic drug effectiveness
It's likely if you're sick, your doctor is more inclined to prescribe a brand name drug in place of its generic equivalent.
Merck's Liptruzet: A Cause For Shame?
I have discussed Vytorin several times before. The combination of Zetia , the cholesterol absorption inhibitor discovered at Schering-Plough, with Merck's simvastatin looked as if it should be a very effective cholesterol-lowering medication, but the real-world data have been consistently puzzling .
Why Drug Giants Are Selling Fewer Pills Than They Used To
One thing that you may not realize about big drug companies is that, in terms of the number of pills they sell, they are much less big than they were just five years ago.
U.S. spending on medicines fell for first time in 2012
Patent expirations on big-name drugs such as Lipitor and Plavix has resulted in modestly less spending on medicines in the United States for the first time in at least 55 years, according to a report released on Thursday.
Wed May 08, 2013
The Motley Fool
Is the Golden Age of Blockbusters Over?
Only 19 drugs have ever netted at least $5 billion in annual sales -- and most were at their peak --according to a list compiled by Simon King of Forbes earlier this year.
What Are Statins?
Millions of people take statins, which are drugs that chemically lower the levels of cholesterol in the blood.